The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca.
Longstanding members of Britest, AstraZeneca first received Britest training in 2004. Since then the tools have primarily been used in process development, both in the areas of API and drug product. AstraZeneca has been active in several Britest innovation projects and external collaborative projects including F3 Factory (modular chemical production and process intensification), and SYNFLOW (continuous processing). More recently, AstraZeneca has also participated alongside Britest as partners in the supply chain and digital design oriented projects,D3P, ReMediES and ADDoPT. .